In vivo buccal delivery of the peptide drug buserelin with glycodeoxycholate as an absorption enhancer in pigs

Pharmaceutical Research

Volumn 13, Issue 8, 1996, Pages 1233-1237

  Hoogstraate, A Janet ^a,c   Verhoef, J Coos ^a   Pijpers, Anton ^b   Van Leengoed, Leo A M G ^b   Verheijden, Jos H M ^b   Junginger, Hans E ^a   Boddé, Harry E ^a  

^a LEIDEN UNIVERSITY   (Netherlands)

^b UTRECHT UNIVERSITY   (Netherlands)

^c ASTRAZENECA R AND D   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

BUSERELIN; GLYCODEOXYCHOLIC ACID;

ANIMAL EXPERIMENT; ARTICLE; BIOAVAILABILITY; BUCCAL DRUG ADMINISTRATION; CONTROLLED STUDY; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG DETERMINATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RADIOIMMUNOASSAY; STEADY STATE; TECHNIQUE;

ADMINISTRATION, ORAL; ANIMALS; BUSERELIN; GLYCODEOXYCHOLIC ACID; INJECTIONS, INTRAVENOUS; MALE; MODELS, BIOLOGICAL; SWINE;

EID: 0029759228     PISSN: 07248741     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1016024606221     Document Type: Article

References (20)

1. V. H. L. Lee, Enzymatic barriers to peptide and protein absorption and the use of penetration enhancers to modify absorption. In: S. S. Davis, L. Illum and E. Tomlinson (eds.), Delivery systems for peptide drugs, Plenum Press, New York 1986, pp. 87-104.
2. H. P. Merkle and G. Wolany. Buccal delivery for peptide drugs. J. Control. Rel. 21:155-164 (1992).
3. W. Schurr, B. Knoll, R. Ziegler, R. Anders and H. P. Merkle. Comparative study of intravenous, nasal, oral and buccal TRH administration among healthy subjects. J. Endocrinol. Invest. 8:41-44 (1985).
4. J. Sandow, G. Jerabek-Sandow, B. Krauss and M. Schmidt-Gollwitzer. Pharmacokinetic and metabolism of LHRH agonists, clinical aspects. In: F. Labrie, A. Belanger, A. Dupont (eds.), LHRH and its analogues, Elsevier Science Publ. Amsterdam, 1984, pp. 123-137.
5. J. Sandow and W. Petri. Intranasal administration of peptides, biological activity and therapeutic efficacy. In: Y. W. Chien (eds.), Transnasal systemic medications, Elsevier Science Publ. Amsterdam, 1985, pp. 183-199.
6. V. H. L. Lee, A. Yamamoto and U. Bhaskar. Mucosal penetration enhancers for facilitation of peptide and protein drug absorption. Crit. Rev. Ther. Drug Carrier Syst. 8:91-192 (1991).
7. B. J. Aungst and N. J. Rogers. Comparison of the effects of various transmucosal absorption promoters on buccal insulin delivery. Int. J. Pharm. 53:227-235 (1989).
8. Y. Lee and Y. W. Chien. Oral mucosal delivery of LHRH: (II) Enhancement of permeation by bile salts and evaluation of mechanism. Pharm. Res. 11:S300 (1994).
9. C. D. Ebert, S. J. Heiber, S. C. Dave, S. W. Kim and D. Mix. Mucosal delivery of macromolecules. J. Control Rel. 28:37-44 (1994).
10. J. Zhang, S. Niu, C. Ebert and T. H. Stanley. An in vivo dog model for studying recovery kinetics of the buccal mucosa permeation barrier after exposure to permeation enhancers: apparent evidence of effective enhancement without tissue damage. Int. J. Pharm. 101:15-22 (1994).
11. Y. Nakada, N. Awata, Y. Ikuta, S. Goto. The effects of bile salts on the oral mucosal absorption of human calcitonin in rats. J. Pharmacobio-Dyn. 12:736-743 (1989).
12. C. A. Lesch, C. A. Squier, A. Cruchley, D. M. Williams, and P. Speight. The permeability of human oral mucosa and skin to water. J. Dent. Res. 68:1345-1349 (1989).
13. J. B. M. M. Van Bree, A. G. De Boer, M. Danhof, J. C. Verhoef, T. B. van Wimersma-Greidanus and D. D. Breimer. Radioimmunoassay of Desglycinamide-Arginine Vasopressin and its application in a pharmacokinetic study in the rat. Peptides 9:555-559 (1988).
14. A. Pijpers, E. N. Noordhuizen-Stassen, S. A. Goedegebuure, O. A. van Dobbenburgh, M. Roosendaal, A. H. M. Cornelissen and J. H. M. Verheijden. Intravenous catheterisation of conventional pigs without application of antimicrobial agents. Vet. Quart. 11:216-221(1989).
15. H. M. Behre, J. Sandow and E. Nieschlag. Pharmacokinetics of the gonadotropin-releasing hormone agonist buserelin after injection of a slow-release preparation in normal men. Arzneim.-Forsch./Drug Res. 42:80-84 (1992).
16. M. Gibaldi and D. Perrier. Pharmacokinetics. In: J. Swarbrick (eds.), Drugs and the pharmaceutical sciences Vol. 1 2nd Ed., Marcel Dekker, New York, 1975, pp. 409-424.
17. J. P. Cassidy, N. M. Landzert and E. Quadros. Controlled buccal delivery of buprenorphine. J. Control. Rel. 25:21-29 (1993).
18. A. J. Hoogstraate, J. C. Verhoef, B. Tuk, A. Pijpers, L. A. M. G. van Leengoed, J. H. M. Verheijden, H. E. Junginger and H. E. Boddé. In-vivo buccal delivery of FITC dextran 4400 with glycodeoxycholate as an absorption enhancer in pigs. J. Pharm. Sci., 85:457-460 (1996).
19. C. K. Oh and W.A., Ritschel. Biopharmaceutic aspects of buccal absorption of insulin. Meth. Find. Exp. Clin. Pharmacol. 12:205-212 (1990).
20. S. Senel, A. J. Hoogstraate, F. Spies, J. C. Verhoef, A. Bos-van Geest, H. E. Junginger and H. E. Boddé. Enhancement of in-vitro permeability of porcine buccal mucosa by bile salts: kinetic and histological studies. J. Control. Rel. 32:45-56 (1994).